Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Dr Donna-Bea Tillman joins Ethics Talk to discuss her article: "What Should the Public Know About Implantable Material and Device Innovation in the US?"
Kelly Leonard, executive director of insights and applied improvisation at Second City Works, relates how improvisation can help clinicians build relationships with patients and improve their outcomes.
Dr Ilisa B. G. Bernstein joins Ethics Talk to discuss her article, coauthored with Karin L. Bolte: “Is My Patient Taking an Unsafe Dietary Supplement?”
Elizabeth Richardson joins Ethics Talk to discuss her article, coauthored Farzana Akkas and Dr Amy B. Cadwallader: “What Should Dietary Supplement Oversight Look Like in the US?”
Dr Alexander Ding joins Ethics Talk to discuss his article, coauthored with Dr Amy B. Cadwallader and other members of the AMA Council on Science and Public Health: “Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?”
Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Dr Rajani Katta joins Ethics Talk to discuss her article, coauthored with Dina H. Zamil, Emily K. Burns, and Dr Ariadna Perez-Sanchez: “Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements?”
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.